Clinical Trial Update: Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated how useful a Risperdal Consta treatment guidebook is for doctors when adults with schizophrenia or schizoaffective disorder switch fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED